B Cell Lymphoma

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology ...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that it has achieved the target enrollment of the minimum

HENDERSON, Nev.--(BUSINESS WIRE)--SPECTRUM PHARMACEUTICALS COMPLETES ENROLLMENT IN THE BELINOSTAT PIVOTAL TRIAL FOR RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Constellation Pharmaceuticals Announces Publication Demonstrating Pharmacological Suppression of Key Cancer-causing Gene

PLANEGG-MARTINSRIED, Germany--(BUSINESS WIRE)--4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US Food and Drug Administration (FDA)